Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Harris Wang
Columbia University Health Sciences, Department: Biochemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
SNIPR Biome
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
SNIPR Biome’s work is broadly related to research being carried out under this grant. In light of the relatedness of the research, in combination with Dr. Wang’s dual roles as study PI and equity-entitled member of the SNIPR scientific advisory board, Columbia's FCOI Committee found a possibility that Dr. Wang’s significant financial interest in SNIPR Biome could directly and significantly affect the design, conduct or reporting of the R01.
Micron-scale Spatial Metagenomic Mapping of Microbial Biogeography in the Gastrointestinal Tract
Dysbiosis of the gut microbiome is associated with a variety of gastrointestinal, inflammatory, metabolic and systemic diseases, but detailed understanding of how microbes colonize the gastrointestinal tract is not available. This proposal aims to develop a new high-throughput and unbiased method to map the spatial biogeography of gut microbiota at a micron-size spatial resolution and will delineate this microbiome organization and function using a well-established mice gut model. The results of this study will have direct relevance for understanding microbial colonization of the mammalian gut in both healthy and diseased states to improve clinical strategies to promote or modify gut microbiota states through prebiotics, probiotics, antibiotics, or microbiota transplantation manipulations.
Filed on July 26, 2019.
Tell us what you know about Harris Wang's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Harris Wang”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Harris Wang | Columbia University Health Sciences | Conflict of Interest | SNIPR Biome | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.